System Transmission

Top Signal

100#1 JOB

Activity

2165Ripe

+919 today

System

Livenow

Terminal Asset View

stockNASDAQ

CGEN

$2.24+1.36%

Compugen Ltd

Ripening

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

55Ripening

Live Analysis Active

Company Mission

Compugen Ltd creates cancer drugs by using computer algorithms to predict which proteins in the body might be good targets for treatment. Pharmaceutical companies use these predictions to develop new therapies, helping patients with hard-to-treat cancers. The company makes money by partnering with these larger firms, sharing revenue from successful drugs.

CGE

Industry Context

This company operates in the biotechnology sector, focusing on drug discovery for cancer treatments. It uses computational methods to identify new drug targets, which is a growing field in personalized medicine. The industry is competitive but offers high rewards for successful therapies. Investors should watch for clinical trial results and partnership announcements.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

41Matrix

Market Momentum

62.7— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

1.36%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing CGEN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:20 AM UTC

Develops cancer drugs using computer models to predict protein interactions, earning revenue through partnerships with larger pharmaceutical companies.

Technical indicators are unavailable, but monitor for price action near $2 as a key support level, suggesting stability if it holds.

Volume data is missing, but watch for any spike above average at $2, indicating potential buyer interest in this biotech stock.

Industry trends in personalized medicine are driving growth, with price holding above $2, signaling resilience. Watch for sector momentum in healthcare.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...